Abstract
Class II prescriptions are known to dissolve ineffectively in both natural and fluid solvents, making them a significantly more challenging challenge. When it comes to these kinds of high log P synthetic compounds that are insoluble in water, the nanosuspension structure is desired. The overall bioavailability of nanosuspensions is influenced by an increase in surface area and a decrease in molecule size. Sometimes the oral dosage forms of water-soluble drugs that are slowly absorbed and inefficient show insufficient bioavailability. A drug's permeability and solubility have a significant impact on how bioavailable it is. To create sub-micron-sized particles, a suitable emulsifier and a pharmaceutical mixture are fed through a high-pressure homogenization or milling procedure. Both classic milling and precipitation processes are commonly used to create particles larger than one millimetre. In this investigation, the techniques was used to prepare the nanosuspension for improving the solubility of poorly soluble drugs.
Reference44 articles.
1. Müller RH, Peters K. Nanosuspensions for the formulation of poorly soluble drugs: I. Preparation by a size-reduction technique. International Journal of Pharmaceutics. 1998;160(2):229–37.
2. Nagaraju., Krishnachaithanya., Srinivas., Padma. Nanosuspensions: A promising drug delivery systems. PCI- Approved-IJPSN [Internet]. 2010;2(4):679–84. Available from: http://dx.doi.org/10.37285/ijpsn.2009.2.4.1
3. Patravale VB, Date AA, Kulkarni RM. Nanosuspension: A promising drug delivery strategy. Journal of Pharmacy and Pharmacology. 2004;56(7):827–40.
4. Geetha G, Poojitha U, Khan A. Various techniques for preparation of nanosuspension - a review. International Journal of Pharma Research & Review. 2014;3(9):30–7.
5. Keck CM, Müller RH, Liversidge GG, Conzentino P, Müller RH, Peters K, et al. Formation of fine drug particles by co-grinding with cyclodextrin. I. the use of beta-cyclodextrin anhydrate and hydrate. International Journal of Pharmaceutics. 1995;62(1):171–4.